For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
28 July 2021
Mary Elizabeth C. Stern and Lucy P. Allen
In their 13th annual review of recent trends in filings and settlements in asbestos litigation, NERA Director Mary Elizabeth C. Stern and Managing Director Lucy P. Allen use publicly available data to analyze trends in asbestos-related liabilities for more than 150 asbestos defendants spanning from 2001 to 2020.
Highlights from this year’s report include:
In addition to reviewing 10-K filings with the US Securities and Exchange Commission (SEC) for 2020, the authors collected data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program on the incidence of mesothelioma diagnoses in the United States. The authors found that mesothelioma incidence dropped 12% in 2018, falling to the lowest level since 2010.
Please contact the authors if you would like NERA to analyze your asbestos data in conjunction with that of other public companies in a benchmarking study.